Fetomaternal outcome in pregnant women with epilepsy in a tertiary care hospital: a retrospective study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20243436Keywords:
Antiepileptic drugs, Epilepsy, Feto maternal outcome, Pregnancy, SeizuresAbstract
Background: Epilepsy is the second common chronic neurological disorder complicating pregnancy after migraine. Incidence of seizure disorder in women attending antenatal clinics is estimated to be 0.3-0.5% of all births. These pregnancies are a challenge to patient and clinician, the double burden of seizures and the antiepileptic drugs (AED) exposure are responsible for the poorer outcome of infants. The aim of the study is to analyse the fetal and maternal outcome in pregnancies that are complicated by epilepsy.
Methods: This was a single centre retrospective study on pregnant women with epilepsy at a tertiary care centre from the period of 01st August 2021 to 1st August 2024. The data of all booked antenatal patients diagnosed with epilepsy was collected from the labour records and electronic medical records. Details included in the study were preconceptionally counselling, age, parity, gestational age at the time of delivery, age of onset of epilepsy, duration of epilepsy, seizure during pregnancy, antiepileptic drug usage in pregnancy, maternal complications and fetal outcomes.
Results: Out of the total 6400 deliveries over in our institution I identified 54 patients with epilepsy complicating pregnancy thus giving a incidence of 0.84 %. Majority of patients were in the age group of 20-30 years . Having a duration of seizures more than 10 years. 87.03 % of patient had GTCS type of seizure and 68.51% of patient gave a history of seizure free period prior to pregnancy. 24.07 % of patients had incidence of antepartum seizures, though most of the patients didn’t need any change in dose or medication. Even with the episodes of antepartum seizures 83.34% of females had a term delivery, 59.25 % patients had a normal delivery and 59.25 % of babies were >2.5 kg at the time of birth. Only 1 child was born with congenital anomalies and 25.92% children required NICU admission.
Conclusions: In this study we observed that though pregnancy with epilepsy needs comprehensive antenatal care and this results in uneventful pregnancies with good feto-maternal outcome.
Metrics
References
Thomas SV. Management of epilepsy and pregnancy. J Postgrad Med. 2006;52:57-64.
Morrel MJ. Epilepsy in women. Am Fam Physician. 2002;66:1489-94.
Nathan J. Women with epilepsy. J Obstet Gynecol India. 2004;54:543-53.
Jeha LE, Morris HH. Optimizing outcomes in pregnant women with epilepsy. Cleve Clin J Med. 2005;72:938-45.
Sveberg L, Svalheim S, Taubøll E: The impact of seizures on pregnancy and delivery. Seizure. 2015;2:1059–311.
Kjaer D, Horvath-Puhó E, Christensen J, Vestergaard M, Czeizel AE, Sørensen HT, et al. Antiepileptic drug use, folic acid supplementation, and congenital abnormalities: a population-based case-control study. BJOG. 2008;11:98–103.
Lindhout D, Omtzigt JG: Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age. Epilepsia. 1994;35,19–28.
Adab N, Kini U, Vinten J, Ayres J, Baker G, Clayton-Smith J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry. 2004;75:1575-83.
Meador KJ, Baker GA, Finnell RH, Kalayjian LA, Liporace JD, Loring DW, et al. Study group: inutero antiepileptic drug exposure: Fetal death and malformations. Neurol. 2006;67:407–12.
Sharma P, Malik R. Fetomaternal outcome in women with heart disease in urban population in a tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2018;7(9):3684.
Raji C, Sekar D. Prospective study of fetomaternal outcome in epilepsy in pregnancy in a tertiary care hospital. Int J Reprod, Contracept, Obst Gynecol. 2017;6(11):5055-60.
Hiralal K, Chaudhuri S. Pregnancy complicated by maternal heart disease: a review of 281 women. J Obstet Gynecol. 2012;62(3):301-6.
Bangal VB, Singh RK, Shinde KK. Clinical study of heart disease complicating pregnancy. IOSR J Pharma. 2012;2(4):25-8.
Sheela CN, Karanth S, Patil CB. Maternal cardiac complications in women with cardiac disease in pregnancy. Int J Pharm Biomed Res. 2011;2(4):261- 5.
Nagamani G, Bhavani K, Isukapalli V, Lagudu S. Heart disease in pregnancy prospective study from southern India. Int J Current Med Appl Sci. 2015;6(1):8-12.
Malik R, Kumar V, Chaudhary S, Duhan N. Obstetric and neonatal outcome in women with epilepsy. Int J Reprod Contracept Obstet Gynecol. 2017;6(6):2593-6.
Goel P, Devi L, Saha PK, Takkar N, Huria A, Dua D. Maternal and perinatal outcome in pregnancy with epilepsy. Internet J Gynecol Obstet. 2006;5:45-9.
Ozdemir O, Sari ME, Kurt A, Sakar VS, Atalay CR. Pregnancy outcome of 149 pregnancies in women with epilepsy: Experience from a tertiary care hospital. Interv Med Appl Sci. 2015;7(3):108–13.
Thomas SV, Sindhu K, Ajaykumar B, Devi PBS, Sujamol J. Maternal and obstetric outcome of women with epilepsy. Seizure. 2009;1;18(3):163–6.
Singh S, Anand TV. An observational study of obstetric and neonatal outcome of pregnancy in women with epilepsy in a tertiary care hospital. Eur J Cardiovas Med. EBSC. 2023;13:1698.
